Russo Evangelos Gastroenterologist

PhD/ Thesis

• 2015 – Imperial College London: “The application of novel imaging modalities in the monitoring of inflammatory activity in Crohn’s disease”

Board Member

• General Medical Council – UK

• Royal College of Physicians – UK

• British Society of Gastroenterology

• United European Gastroenterology

• Iatrikos Syllogos Athinas

Professional Experience

• 01/2017- present: Consultant Gastroenterologist Imperial College Healthcare NHS Trust Honorary Lecturer– Imperial College London

• 08/2008-12/2016: Specialist Registrar in Gastroenterology/ Internal Medicine North West Thames Rotation, London UK

• 10/2010 – 09/2014: Research Fellowship – PhD Imperial College London

• 08/2003 – 07/2008: Specialist Training in General Internal Medicine Hertfordshire/ Kent/ London Rotation

Education Experience

• June 2020 Digital Gastro Trainee Network: Management of GI Bleeds, Online Teaching

• January2020 Imperial GI Bleed Course, Hammersmith Hospital, London UK

• November 2019 LOGIC IBD Nurse Education and Recognition. “A Clinical update on Microscopic Colitis” London, UK

• October 2019 An Update on Microscopic Colitis, Tillott’s Satellite Symposium, Barcelona, SP

• November 2018 Advances in Microscopic Colitis – An Educational Symposium, London UK

• April 2017 The management of fistulising Crohn’s Disease. The Allergan 6th Scientific Meeting in Digestive Diseases, London, UK

Clinical and Research Interest

Clinical Interest:

• Diagnostic and Therapeutic Endoscopy

• Polypectomy

• Chronic diarrhoea and change in bowel habit

• Inflammatory Bowel Disease including Microscopic Colitis

• Malignancies of the GI tract

Research Interest: 

• Inflammatory Bowel Disease

• Microscopic Colitis – Member of the European Microscopic Colitis Group

• New developments of therapeutic endoscopy

Awards

• The Erickson Liston Prize in Surgery, UCL Medical School

• Wellcome Trust/ GSK Translational Medicine Training Fellowship

Recent Publications

1. BP Verhaeg, A Munch, D Guagnozzi, S Wildt, W Cebula, A Diac, F Fernandez-Benares, M Al-Khalaf, Pedersen N, Kupcinskas J, Bohr J, A Lucendo, Lyutakov I, GE Tontini, F Pigo, E Russo, H Hjwortswang , S Miehlke , L Munck. Course of disease in patients with microscopic colitis – a European prospective incident cohort study. Journal of Crohns and Colitis J Crohns Colitis 2021 Jul 5;15(7):1174-1183

2. P Boger, I Rahman, M Hu, L Ayaru, P Bhandari, F Chedgy, S Green, M Hayat, A Hopper, D Andrew, Ishaq, J Martin, I McCallum, P Phull, S Pugh, E Russo, N Suzuki, Noriko, S Thomas-Gibson, Z Zeino, P Patel. Endoscopic full thickness resection in the colo-rectum: outcomes from the UK Registry Eur J Gastroenterol Hepatol 2021 Jun 1;33(6):852-858

3. EA Russo, SA Khan, R Janisch, RN Gunn, EA Rabiner, SA Taylor, PM Matthews, TR Orchard. The role of 18F-fluorodeoxyglucose positron emission tomography in the monitoring of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis 2016 Nov;22(11):2619-2629

4. A Plumb, A Menys, EA Russo, D Prezzi, G Bhatnagar, R Vega, S Halligan, TR Orchard, SA Taylor. Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther. 2015 Aug;42(3):343-55

5. P Kennedy, EA Russo, N Kumar, N Powell, P Vlavianos, A Thillainayagam, D Bansi, D Westaby. Effectiveness of prophylactic pancreatic stents in preventing post-ERCP pancreatitis: A two- year, retrospective controlled study in a tertiary centre in London. Surg Endosc. 2010 Aug;24(8):1923-8

6. EA Russo, M Iacucci, JO Lindsay, S Campbell, JP Hamlin, TR Orchard, N Arebi, AL Hart, SM Gabe, MR Jacyna, J Nightingale, M O’Connor, AW Harris, C O’Morain, S Ghosh. Survey regarding the use of adalimumab as maintenance therapy in Crohn’s disease in England and Ireland. Eur J Gastroenterol Hepatol. 2010 Mar;22(3):334-9.

7. EA Russo, AW Harris, S Campbell, J Lindsay, A Hart, N Arebi, A Milestone, HHTsai, J Walters, M Carpani, D Westaby, A Thillainayagam, D Bansi, S Ghosh. Experience of maintenance infliximab therapy for refractory ulcerative colitis in England. Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14.